ArticleOncoTargets and therapy2016

miR-32 inhibits proliferation, epithelial-mesenchymal transition, and metastasis by targeting TWIST1 in non-small-cell lung cancer cells.

Lei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.